针对治疗乙型肝炎的先天免疫系统:功能治愈的前景
Karen Cheuk-Ying Ho1, Rex Wan-Hin Hui1, Wai-Kay Seto1,2
1Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.
实现慢性乙型肝炎 (CHB) 的功能治疗是困难的. 针对乙型肝炎病毒 (HBV) 生命周期和先天性免疫逃避的新疗法正在出现,以改善CHB治疗结果.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
背景情况:
- 慢性乙型肝炎 (CHB) 是一个主要的全球健康问题.
- 目前的治疗方法如NUC和Peg-IFNα在实现功能治愈方面存在局限性.
- 乙型肝炎病毒 (HBV) 逃避宿主天生的免疫系统,导致慢性感染.
研究的目的:
- 审查HBV生命周期与宿主天生的免疫系统之间的相互作用.
- 讨论针对CHB功能治疗的先天免疫力的新型治疗剂.
- 突出用于CHB管理的新兴策略.
主要方法:
- 关于HBV与宿主先天性免疫相互作用的综合文献综述.
- 对针对先天性免疫逃避策略的新型治疗剂的分析.
- 评估包括RIG-I激动剂,TLR激动剂,干扰素,siRNAs和反感性寡核化物在内的疗法.
主要成果:
- 乙型肝炎病毒使用机制来逃避宿主天生的免疫力,从而导致慢性.
- 像RIG-I激动剂和TLR激动剂这样的新型药物直接准HBV逃避.
- siRNAs和反感性寡核酸具有超出抗原淘汰的潜力,影响天生的免疫力.
结论:
- 了解HBV与先天免疫的相互作用是开发功能治疗策略的关键.
- 针对先天免疫的新兴疗法为CHB治疗提供了新的希望.
- 预计结合策略和正在进行的研究将推动CHB管理.
更多相关视频
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
相关概念视频
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
